Denali Therapeutics Inc (DNLI)
20.52
+0.28
(+1.38%)
USD |
NASDAQ |
May 17, 16:00
20.52
0.00 (0.00%)
After-Hours: 20:00
Denali Therapeutics Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.42M |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 9.282M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | 15.22M |
| March 31, 2021 | |
| December 31, 2020 |
| Date | Value |
|---|---|
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
3.42M
Minimum
Dec 2023
15.22M
Maximum
Jun 2021
9.307M
Average
9.282M
Median
Dec 2022
Accounts Receivable (Quarterly) Benchmarks
| Halozyme Therapeutics Inc | 191.52M |
| AIM ImmunoTech Inc | -- |
| Perspective Therapeutics Inc | 0.999M |
| Protalix BioTherapeutics Inc | 3.759M |
| Armata Pharmaceuticals Inc | -- |